Cargando…
Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
BACKGROUND: The transmembrane transporter Sema3D is a vital molecule involved in axon guidance and carcinogenesis of variant malignancies. However, the relationship between Sema3D and clear cell renal cell carcinoma (ccRCC) is barely reported and remains unclear. METHODS: Sema3D expression and the c...
Autores principales: | Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Cao, Chuanzhen, Bi, Xingang, Shi, Hongzhe, Shou, Jianzhong, Guan, Youyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262505/ https://www.ncbi.nlm.nih.gov/pubmed/35813868 http://dx.doi.org/10.1155/2022/3204189 |
Ejemplares similares
-
Optimizing targeted drug selection in combination therapy for patients with advanced or metastatic renal cell carcinoma: A systematic review and network meta‐analysis of safety
por: Xie, Ruiyang, et al.
Publicado: (2022) -
Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis
por: Xie, Ruiyang, et al.
Publicado: (2021) -
A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma
por: Cao, Chuanzhen, et al.
Publicado: (2022) -
Novel cut‐off values of time from diagnosis to systematic therapy predict the overall survival and the efficacy of targeted therapy in renal cell carcinoma: A long‐term, follow‐up, retrospective study
por: Cao, Chuanzhen, et al.
Publicado: (2021) -
Neutrophil extracellular traps primed intercellular communication in cancer progression as a promising therapeutic target
por: Shang, Bingqing, et al.
Publicado: (2023)